ACADIA Pharmaceuticals Inc.
ACAD
Classificação em ações
#4449
ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily... ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders. The company's marketed product, NUPLAZID (pimavanserin), is prescribed for the management of hallucinations and delusions associated with Parkinson's disease psychosis. Beyond its commercialized offering, ACADIA maintains a robust development pipeline, featuring several promising candidates: Pimavanserin: This compound is currently undergoing Phase 3 clinical trials for additional indications, specifically for Alzheimer's disease psychosis and the negative symptoms of schizophrenia. Trofinetide: A novel synthetic compound, Trofinetide is also in Phase 3 development, aimed at treating Rett syndrome. ACP-044: This orally administered, first-in-class non-opioid analgesic is progressing through Phase 2 studies for both acute and chronic pain. ACP-319: Identified as a positive allosteric modulator of the muscarinic receptor, ACP-319 is in Phase 1 development, exploring its potential for schizophrenia and improving cognition in Alzheimer's patients. Established in 1993, ACADIA Pharmaceuticals Inc. is headquartered in San Diego, California.
Preço da ação
$20.31
Valor de mercado
$3.50B
Variação (1 dia)
2.55%
Variação (1 ano)
-3.03%
País
US
Negociar ACADIA Pharmaceuticals Inc. (ACAD)
Categoria
Healthcare
Histórico de desdobramentos de ações de ACADIA Pharmaceuticals Inc. (ACAD)
As ações ACADIA Pharmaceuticals Inc. (símbolo: ACAD) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Oct 20, 2026.
Uma ação ACAD comprada antes de Oct 20, 2026 equivaleria hoje a 0 ações ACAD.
O desdobramento mais recente ocorreu em Oct 20, 2026.
Uma ação ACAD comprada antes de Oct 20, 2026 equivaleria hoje a 0 ações ACAD.
Lista de desdobramentos de ações
| Ano | Desdobramento | Multiplicador | Multiplicador cumulativo |
|---|---|---|---|
| Não há dados suficientes para as datas fornecidas. | |||
Desdobramentos de ações de empresas semelhantes ou concorrentes
| Empresa | Número de desdobramentos de ações | Multiplicador cumulativo | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
